{"pmid":32202336,"title":"Nursing and the Novel Coronavirus: Risks and Responsibilities in a Global Outbreak.","text":["Nursing and the Novel Coronavirus: Risks and Responsibilities in a Global Outbreak.","In December of 2019, reports emerged of pneumonia clusters of unknown cause at health facilities in Wuhan, China. These cases were linked to a wet animal wholesale market in the region and, after extensive epidemiologic investigation, led to identification of a novel coronavirus (COVID-19). COVID-19 is among a family of viruses-called coronaviruses-that can affect both humans and animals (Zhu et al., 2020).","J Adv Nurs","Choi, Kristen R","Skrine Jeffers, Kia","Logsdon, M Cynthia","32202336"],"abstract":["In December of 2019, reports emerged of pneumonia clusters of unknown cause at health facilities in Wuhan, China. These cases were linked to a wet animal wholesale market in the region and, after extensive epidemiologic investigation, led to identification of a novel coronavirus (COVID-19). COVID-19 is among a family of viruses-called coronaviruses-that can affect both humans and animals (Zhu et al., 2020)."],"journal":"J Adv Nurs","authors":["Choi, Kristen R","Skrine Jeffers, Kia","Logsdon, M Cynthia"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32202336","week":"202013|Mar 23 - Mar 29","doi":"10.1111/jan.14369","source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1662090442883203072,"score":6.998814,"similar":[{"pmid":32202824,"title":"The novel coronavirus (COVID-2019) outbreak: Amplification of public health consequences by media exposure.","text":["The novel coronavirus (COVID-2019) outbreak: Amplification of public health consequences by media exposure.","The 2019 novel coronavirus (COVID-2019) has led to a serious outbreak of often severe respiratory disease, which originated in China and has quickly become a global pandemic, with far-reaching consequences that are unprecedented in the modern era. As public health officials seek to contain the virus and mitigate the deleterious effects on worldwide population health, a related threat has emerged: global media exposure to the crisis. We review research suggesting that repeated media exposure to community crisis can lead to increased anxiety, heightened stress responses that can lead to downstream effects on health, and misplaced health-protective and help-seeking behaviors that can overburden health care facilities and tax available resources. We draw from work on previous public health crises (i.e., Ebola and H1N1 outbreaks) and other collective trauma (e.g., terrorist attacks) where media coverage of events had unintended consequences for those at relatively low risk for direct exposure, leading to potentially severe public health repercussions. We conclude with recommendations for individuals, researchers, and public health officials with respect to receiving and providing effective communications during a public health crisis. (PsycInfo Database Record (c) 2020 APA, all rights reserved).","Health Psychol","Garfin, Dana Rose","Silver, Roxane Cohen","Holman, E Alison","32202824"],"abstract":["The 2019 novel coronavirus (COVID-2019) has led to a serious outbreak of often severe respiratory disease, which originated in China and has quickly become a global pandemic, with far-reaching consequences that are unprecedented in the modern era. As public health officials seek to contain the virus and mitigate the deleterious effects on worldwide population health, a related threat has emerged: global media exposure to the crisis. We review research suggesting that repeated media exposure to community crisis can lead to increased anxiety, heightened stress responses that can lead to downstream effects on health, and misplaced health-protective and help-seeking behaviors that can overburden health care facilities and tax available resources. We draw from work on previous public health crises (i.e., Ebola and H1N1 outbreaks) and other collective trauma (e.g., terrorist attacks) where media coverage of events had unintended consequences for those at relatively low risk for direct exposure, leading to potentially severe public health repercussions. We conclude with recommendations for individuals, researchers, and public health officials with respect to receiving and providing effective communications during a public health crisis. (PsycInfo Database Record (c) 2020 APA, all rights reserved)."],"journal":"Health Psychol","authors":["Garfin, Dana Rose","Silver, Roxane Cohen","Holman, E Alison"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32202824","week":"202013|Mar 23 - Mar 29","doi":"10.1037/hea0000875","source":"PubMed","locations":["H1N1","Ebola","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1662090442964992000,"score":99.316154},{"pmid":32202258,"title":"Guidance for building a dedicated health facility to contain the spread of the 2019 novel coronavirus outbreak.","text":["Guidance for building a dedicated health facility to contain the spread of the 2019 novel coronavirus outbreak.","Preparedness for the ongoing coronavirus disease 2019 (COVID-19) and its spread in India calls for setting up of adequately equipped and dedicated health facilities to manage sick patients while protecting healthcare workers and the environment. In the wake of other emerging dangerous pathogens in recent times, such as Ebola, Nipah and Zika, it is important that such facilities are kept ready during the inter-epidemic period for training of health professionals and for managing cases of multi-drug resistant and difficult-to-treat pathogens. While endemic potential of such critically ill patients is not yet known, the health system should have surge capacity for such critical care units and preferably each tertiary government hospital should have at least one such facility. This article describes elements of design of such unit (e.g., space, infection control, waste disposal, safety of healthcare workers, partners to be involved in design and plan) which can be adapted to the context of either a new construction or makeshift construction on top of an existing structure. In view of a potential epidemic of COVID-19, specific requirements to handle it are also given.","Indian J Med Res","Agarwal, Anup","Nagi, Nazia","Chatterjee, Pranab","Sarkar, Swarup","Mourya, Devendra","Sahay, Rima Rakeshkumar","Bhatia, Rajesh","32202258"],"abstract":["Preparedness for the ongoing coronavirus disease 2019 (COVID-19) and its spread in India calls for setting up of adequately equipped and dedicated health facilities to manage sick patients while protecting healthcare workers and the environment. In the wake of other emerging dangerous pathogens in recent times, such as Ebola, Nipah and Zika, it is important that such facilities are kept ready during the inter-epidemic period for training of health professionals and for managing cases of multi-drug resistant and difficult-to-treat pathogens. While endemic potential of such critically ill patients is not yet known, the health system should have surge capacity for such critical care units and preferably each tertiary government hospital should have at least one such facility. This article describes elements of design of such unit (e.g., space, infection control, waste disposal, safety of healthcare workers, partners to be involved in design and plan) which can be adapted to the context of either a new construction or makeshift construction on top of an existing structure. In view of a potential epidemic of COVID-19, specific requirements to handle it are also given."],"journal":"Indian J Med Res","authors":["Agarwal, Anup","Nagi, Nazia","Chatterjee, Pranab","Sarkar, Swarup","Mourya, Devendra","Sahay, Rima Rakeshkumar","Bhatia, Rajesh"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32202258","week":"202013|Mar 23 - Mar 29","doi":"10.4103/ijmr.IJMR_518_20","keywords":["Biocontainment","biosafety","coronavirus","designated health facility","infection prevention and control"],"source":"PubMed","locations":["Zika","India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1662090442937729024,"score":96.52891},{"pmid":31978945,"title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019.","text":["A Novel Coronavirus from Patients with Pneumonia in China, 2019.","In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia. Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily. Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans. Enhanced surveillance and further investigation are ongoing. (Funded by the National Key Research and Development Program of China and the National Major Project for Control and Prevention of Infectious Disease in China.).","N Engl J Med","Zhu, Na","Zhang, Dingyu","Wang, Wenling","Li, Xingwang","Yang, Bo","Song, Jingdong","Zhao, Xiang","Huang, Baoying","Shi, Weifeng","Lu, Roujian","Niu, Peihua","Zhan, Faxian","Ma, Xuejun","Wang, Dayan","Xu, Wenbo","Wu, Guizhen","Gao, George F","Tan, Wenjie","31978945"],"abstract":["In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia. Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily. Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans. Enhanced surveillance and further investigation are ongoing. (Funded by the National Key Research and Development Program of China and the National Major Project for Control and Prevention of Infectious Disease in China.)."],"journal":"N Engl J Med","authors":["Zhu, Na","Zhang, Dingyu","Wang, Wenling","Li, Xingwang","Yang, Bo","Song, Jingdong","Zhao, Xiang","Huang, Baoying","Shi, Weifeng","Lu, Roujian","Niu, Peihua","Zhan, Faxian","Ma, Xuejun","Wang, Dayan","Xu, Wenbo","Wu, Guizhen","Gao, George F","Tan, Wenjie"],"date":"2020-01-25T11:00:00Z","year":2020,"_id":"31978945","week":"20204|Jan 20 - Jan 26","doi":"10.1056/NEJMoa2001017","link_comment_in":"32035533","source":"PubMed","locations":["Pneumonia","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["General Info"],"weight":1,"_version_":1661359647179669507,"score":96.103325},{"pmid":32088679,"title":"2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness.","text":["2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness.","On 31 December 2019 the Wuhan Health Commission reported a cluster of atypical pneumonia cases that was linked to a wet market in the city of Wuhan, China. The first patients began experiencing symptoms of illness in mid-December 2019. Clinical isolates were found to contain a novel coronavirus with similarity to bat coronaviruses. As of 28 January 2020, there are in excess of 4,500 laboratory-confirmed cases, with > 100 known deaths. As with the SARS-CoV, infections in children appear to be rare. Travel-related cases have been confirmed in multiple countries and regions outside mainland China including Germany, France, Thailand, Japan, South Korea, Vietnam, Canada, and the United States, as well as Hong Kong and Taiwan. Domestically in China, the virus has also been noted in several cities and provinces with cases in all but one provinence. While zoonotic transmission appears to be the original source of infections, the most alarming development is that human-to-human transmission is now prevelant. Of particular concern is that many healthcare workers have been infected in the current epidemic. There are several critical clinical questions that need to be resolved, including how efficient is human-to-human transmission? What is the animal reservoir? Is there an intermediate animal reservoir? Do the vaccines generated to the SARS-CoV or MERS-CoV or their proteins offer protection against 2019-nCoV? We offer a research perspective on the next steps for the generation of vaccines. We also present data on the use of in silico docking in gaining insight into 2019-nCoV Spike-receptor binding to aid in therapeutic development. Diagnostic PCR protocols can be found at https://www.who.int/health-topics/coronavirus/laboratory-diagnostics-for-novel-co ronavirus.","J Infect Dev Ctries","Ralph, Robyn","Lew, Jocelyne","Zeng, Tiansheng","Francis, Magie","Xue, Bei","Roux, Melissa","Toloue Ostadgavahi, Ali","Rubino, Salvatore","Dawe, Nicholas J","Al-Ahdal, Mohammed N","Kelvin, David J","Richardson, Christopher D","Kindrachuk, Jason","Falzarano, Darryl","Kelvin, Alyson Anne","32088679"],"abstract":["On 31 December 2019 the Wuhan Health Commission reported a cluster of atypical pneumonia cases that was linked to a wet market in the city of Wuhan, China. The first patients began experiencing symptoms of illness in mid-December 2019. Clinical isolates were found to contain a novel coronavirus with similarity to bat coronaviruses. As of 28 January 2020, there are in excess of 4,500 laboratory-confirmed cases, with > 100 known deaths. As with the SARS-CoV, infections in children appear to be rare. Travel-related cases have been confirmed in multiple countries and regions outside mainland China including Germany, France, Thailand, Japan, South Korea, Vietnam, Canada, and the United States, as well as Hong Kong and Taiwan. Domestically in China, the virus has also been noted in several cities and provinces with cases in all but one provinence. While zoonotic transmission appears to be the original source of infections, the most alarming development is that human-to-human transmission is now prevelant. Of particular concern is that many healthcare workers have been infected in the current epidemic. There are several critical clinical questions that need to be resolved, including how efficient is human-to-human transmission? What is the animal reservoir? Is there an intermediate animal reservoir? Do the vaccines generated to the SARS-CoV or MERS-CoV or their proteins offer protection against 2019-nCoV? We offer a research perspective on the next steps for the generation of vaccines. We also present data on the use of in silico docking in gaining insight into 2019-nCoV Spike-receptor binding to aid in therapeutic development. Diagnostic PCR protocols can be found at https://www.who.int/health-topics/coronavirus/laboratory-diagnostics-for-novel-co ronavirus."],"journal":"J Infect Dev Ctries","authors":["Ralph, Robyn","Lew, Jocelyne","Zeng, Tiansheng","Francis, Magie","Xue, Bei","Roux, Melissa","Toloue Ostadgavahi, Ali","Rubino, Salvatore","Dawe, Nicholas J","Al-Ahdal, Mohammed N","Kelvin, David J","Richardson, Christopher D","Kindrachuk, Jason","Falzarano, Darryl","Kelvin, Alyson Anne"],"date":"2020-02-24T11:00:00Z","year":2020,"_id":"32088679","week":"20209|Feb 24 - Mar 01","doi":"10.3855/jidc.12425","keywords":["2019-nCoV","Wuhan","coronavirus","human-to-human transmission","vaccine readiness"],"source":"PubMed","locations":["Canada","Germany","Vietnam","United States","South Korea","Japan","Wuhan","China","France","Thailand"],"countries":["France","United States","Japan","Thailand","Canada","Korea, Republic of","Germany","China","Viet Nam"],"countries_codes":["FRA|France","USA|United States","JPN|Japan","THA|Thailand","CAN|Canada","KOR|Korea, Republic of","DEU|Germany","CHN|China","VNM|Viet Nam"],"topics":["Treatment"],"weight":1,"_version_":1661359647405113344,"score":88.54844},{"pmid":32009128,"title":"History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel Coronavirus Epidemic","text":["History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel Coronavirus Epidemic","Pathogen transmission from a vertebrate animal to a human, also known as zoonotic spillover, represents a global public health burden, which while associated with multiple outbreaks, still remains a poorly understood phenomenon. Coronaviruses, like influenza viruses, circulate in nature in various animal species. Alpha-coronaviruses and beta-coronaviruses can infect mammals and gamma-coronaviruses and delta-coronaviruses tend to infect birds, but some of them can also be transmitted to mammals. Although still preliminary, current data suggest that bats are the most probable initial source of the current 2019 novel CoV (2019nCoV) outbreak, that begun on December 2019 in Wuhan, China, apparently spreading from a \"wet market\" to multiple cities and provinces in China. This epidemic of 2019nCoV, already reaching more than 6,000 cases to-day (end of January 2020) (>90% in China), will not be the last one linked to zoonotic spillover events.","Infez Med","Rodriguez-Morales, Alfonso J","Bonilla-Aldana, D Katterine","Balbin-Ramon, Graciela Josefina","Rabaan, Ali A","Sah, Ranjit","Paniz-Mondolfi, Alberto","Pagliano, Pasquale","Esposito, Silvano","32009128"],"abstract":["Pathogen transmission from a vertebrate animal to a human, also known as zoonotic spillover, represents a global public health burden, which while associated with multiple outbreaks, still remains a poorly understood phenomenon. Coronaviruses, like influenza viruses, circulate in nature in various animal species. Alpha-coronaviruses and beta-coronaviruses can infect mammals and gamma-coronaviruses and delta-coronaviruses tend to infect birds, but some of them can also be transmitted to mammals. Although still preliminary, current data suggest that bats are the most probable initial source of the current 2019 novel CoV (2019nCoV) outbreak, that begun on December 2019 in Wuhan, China, apparently spreading from a \"wet market\" to multiple cities and provinces in China. This epidemic of 2019nCoV, already reaching more than 6,000 cases to-day (end of January 2020) (>90% in China), will not be the last one linked to zoonotic spillover events."],"journal":"Infez Med","authors":["Rodriguez-Morales, Alfonso J","Bonilla-Aldana, D Katterine","Balbin-Ramon, Graciela Josefina","Rabaan, Ali A","Sah, Ranjit","Paniz-Mondolfi, Alberto","Pagliano, Pasquale","Esposito, Silvano"],"date":"2020-02-04T11:00:00Z","year":2020,"_id":"32009128","week":"20206|Feb 03 - Feb 09","source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["General Info"],"weight":1,"_version_":1661359647140872193,"score":88.33775}]}